Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Emily R. Cox, PhD

Articles by Emily R. Cox, PhD

Lowering Copayments: Impact of Simvastatin Patent Expiration on Patient Adherence

ByRebecca L. Sedjo, PhD,Emily R. Cox, PhD

December 1st 2008

Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.

Relationship Between Generic and Preferred-brand Prescription Copayment Differentials and Generic Fill Rate

ByDouglas E. Mager, MA,Emily R. Cox, PhD

June 1st 2007

Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy

ByBrenda R. Motheral, PhD,Rochelle Henderson, MPA,Emily R. Cox, PhD

July 1st 2004

Verification of a Decision Analytic Model Assumption Using Real-World Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

ByEmily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BS

December 1st 2003

Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition Therapy

ByEmily R. Cox, PhD,Brenda Motheral, PhD,Mark Frisse, MD*,Andrew Behm, PharmD,Doug Mager, BS

November 1st 2003

Latest Updated Articles

Trending on AJMC

Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains

Defunding Co-Payment Assistance Disrupted nAMD Care

5 Questions Dermatology Patients May Have About Newly-Approved Bemotrizinol